Shots:
- Alcon has entered into a definitive merger agreement to acquire STAAR Surgical Company incl. its asset EVO family of lenses (EVO ICL)
- As per the deal, Alcon will acquire STAAR for a total equity value of ~$1.5B, with its shareholders receiving $28/share in cash; the deal is expected to close within 6-12mos.
- EVO ICLs are implantable lenses placed between the iris & natural lens in a minimally invasive, reversible procedure that does not remove corneal tissue & corrects a broad range of vision issues, incl. myopia with or without astigmatism
Ref: Businesswire | Image: STAAR Surgical | Press Release
Related News:- Concentra Biosciences Enters a Merger Agreement to Acquire iTeos Therapeutics
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
